Comparative analysis of TRX1 expression indicates it is progressively and significantly elevated in going from normal prostate tissue samples to AD-responsive PCa samples to metastatic CRPC samples, further reinforcing an increasing need for TRX1 during progression to incurable PCa (Fig. 1d). The gene discussed is TXN; the disease is posterior cortical atrophy.